Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Stomach Neoplasms 2 Sarcoma 2 Recurrence 2 Melanoma 2 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Lymphoma 1 Liposarcoma 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adrenocortical Carcinoma 1 Adenocarcinoma of Lung 1

Interventions

Doxorubicin 25 Radiotherapy 15 Ifosfamide 14 Trabectedin 10 pazopanib 6 ribociclib 5 pembrolizumab 5 Specimen Handling 5 Gemcitabine 5 Biopsy 5 palbociclib 4 Magnetic Resonance Spectroscopy 4 Docetaxel 4 Chemotherapy, Adjuvant 4 selinexor 3 liposomal doxorubicin 3 eribulin 3 X-Rays 3 Vincristine 3 Radiation 3 Neoadjuvant Therapy 3 Imatinib Mesylate 3 Filgrastim 3 Etoposide 3 Cyclophosphamide 3 toripalimab 2 temsirolimus 2 romidepsin 2 pegfilgrastim 2 cixutumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × milademetan × Clear all

NCT04979442 2025-01-14

MANTRA

Rain Oncology Inc

Phase 3 Terminated

175 enrolled 16 charts

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡